Synopsis
From the editors of the Neurology Journal, Neurology Minute is a daily 1-2 minute brief podcast delivering a quick, practical rundown of what you need to know in neurology. Neurology Minute is hosted by Dr. Stacey Clardy, with contributions by leading neurologists and neuroscientists.
Episodes
-
The Menopause Transition and Epilepsy
22/10/2026 Duration: 01minDr. Katie Krulisky and Dr. Kelsey Smith discuss the impact of menopause on women with epilepsy, including therapeutics and clinical management during midlife. Show citation: Smith KM, Faubion SS, Vadlamudi L, et al. The Menopause Transition and Epilepsy: A Focus on Therapeutics. Neurol Clin Pract. 2026;16(5):e200650. doi:10.1212/CPJ.0000000000200650
-
TRUE-MOGAD Score
21/10/2026 Duration: 02minDr. Casey Kozak discusses a new scoring system for MOGAD identification. Show citation: Vilaseca A, Filippatou AG, Said Y, et al. TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results. Neurol Neuroimmunol Neuroinflamm. 2026;13(5):e200617. doi:10.1212/NXI.0000000000200617
-
Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers
20/10/2026 Duration: 03minDr. Hailey Katulski discusses limb compression therapy and chemotherapy-induced peripheral neuropathy in women with gynecologic cancers. Show citation: Başkurt K, Uyar GC, Yeşilbaş E, et al. Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial). Int J Cancer. 2026;159(9):2300-2313. doi:10.1002/ijc.70601
-
Delusional Misidentification Syndromes - Part 9
19/10/2026 Duration: 03minIn the final episode of this nine-part series, Dr. Christine Cliatt-Brown discusses pharmacologic and non-pharmacologic management.
-
Herpes Zoster Vaccination and Incident Dementia in Canada
16/10/2026 Duration: 02minDr. Margarita Fedorova and Dr. Pascal Geldsetzer discuss how the herpes zoster vaccination may have neuroprotective effects, potentially delaying or preventing dementia. Show citation: Pomirchy M, Chung S, Bommer C, Strobel S, Geldsetzer P. Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments. Lancet Neurol. 2026;25(2):170-180. doi:10.1016/S1474-4422(25)00455-7
-
Understanding the Forces Shaping US Health Care
15/10/2026 Duration: 02minDr. Jason Crowell and Dr. John McDonough discuss the historical and economic factors shaping the US healthcare system and why understanding these systemic forces matters for neurologists and patient care. Show citation: Powell A. How to fix U.S. Healthcare? "Radical Action," says John McDonough. Harvard Gazette. August 18, 2026. Accessed August 20, 2026. https://news.harvard.edu/gazette/story/2026/08/how-to-fix-u-s-healthcare-radical-action-says-john-mcdonough/.
-
Delusional Misidentification Syndromes - Part 8
14/10/2026 Duration: 02minIn the eighth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses delusional companion syndrome.
-
Delusional Misidentification Syndromes - Part 7
13/10/2026 Duration: 02minIn the seventh episode of this nine-part series, Dr. Christine Cliatt-Brown discusses reduplicative paramnesia.
-
Delusional Misidentification Syndromes - Part 6
12/10/2026 Duration: 02minIn the sixth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses Cotard syndrome.
-
Prevalence of CTE at Death in National Football League Players
09/10/2026 Duration: 01minDr. Shuvro Roy and Dr. Daniel Daneshvar discussed the prevalence of CTE at death among NFL players and the association between CTE severity and the risk of dementia. Show citation: Daneshvar DH, Nowinski CJ, Abdolmohammadi B, et al. Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21. BMJ. 2026;394:e100418. Published 2026 Aug 25. doi:10.1136/bmj-2026-100418
-
Clinical Manifestations of Primary CNS T-Cell Lymphoma
08/10/2026 Duration: 01minDr. Kait Nevel and Dr. Katharina Schmidbauer discuss primary CNS T-cell lymphoma, highlighting diagnostic challenges, imaging characteristics, and treatment approaches for this rare disease. Show citation: Schmidbauer KJ, Karschnia P, Kaulen LD, et al. Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features. Neurol. 2026;106(7):e214744. Published 2026 Mar 17. doi:10.1212/WNL.0000000000214744
-
October 2026 President Spotlight: One AAN Community
07/10/2026 Duration: 03minIn the October episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss updates on membership options that will help more neurology professionals connect with the AAN. Stay informed by watching the President's Spotlight video.
-
The Future of Child Neurology Residency Training - Part 2
06/10/2026 Duration: 02minIn part two of this series, Dr. Dara Albert and Dr. Bruce Cohen highlight the most important takeaways from the task force findings. Show citation: Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol Educ. 2026;5(2):e200331. Published 2026 Jun 12. doi:10.1212/NE9.0000000000200331
-
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 2
05/10/2026 Duration: 01minIn the second episode of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim discuss key take-home messages from the guideline recommendations and share insights on integrating them into clinical practice. Show citation: Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Headache. Published online August 31, 2026. doi:10.1111/head.70199
-
The Future of Child Neurology Residency Training - Part 1
02/10/2026 Duration: 02minIn part one of this series, Dr. Dara Albert and Dr. Bruce Cohen discuss why the Child Neurology Society felt it was important to establish a task force to examine child neurology training at this point in time. Show citation: Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol Educ. 2026;5(2):e200331. Published 2026 Jun 12. doi:10.1212/NE9.0000000000200331
-
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 1
01/10/2026 Duration: 01minIn the first part of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim provide a brief overview of the guideline recommendations for pharmacologic treatment of migraine prevention in adults. Show citation: Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Headache. Published online August 31, 2026. doi:10.1111/head.70199
-
Delusional Misidentification Syndromes - Part 5
30/09/2026 Duration: 02minIn the fifth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses syndrome of subjective doubles.
-
Delusional Misidentification Syndromes - Part 4
29/09/2026 Duration: 03minIn the fourth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses mirrored self-misidentification syndrome.
-
Delusional Misidentification Syndromes - Part 3
28/09/2026 Duration: 02minIn the third episode of this nine-part series, Dr. Christine Cliatt-Brown discusses Fregoli syndrome.
-
Resolution of PML after Treatment with Virus-Specific T Cells and HCT
25/09/2026 Duration: 03minDr. Justin Abbatemarco and Dr. Irene Cortese discuss recent advances in the treatment of progressive multifocal leukoencephalopathy (PML), focusing on immune-based therapies like virus-specific T cells and immune checkpoint inhibitors. Show citation: Gonzalez CE, Fletcher A, Jenkins TL, et al. Resolution of PML after Treatment with Virus-Specific T Cells and HCT. N Engl J Med. 2026;394(20):2061-2064. doi:10.1056/NEJMc2514186